Xeris Pharmaceuticals | XERS - EPS Earnings Per Share


Xeris Pharmaceuticals reported $0 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2027Q1 Mar/2026 0.01 -0.06 May/07 2026




Eps Change Date
Celltrion KRW 1.55K 422.43 Mar/2026
Cspc Pharmaceutical CNY 0.08 0.01 Sep/2025
Deva Holding AS TRY 2.92 1.6 Sep/2023
Dianthus Therapeutics USD -0.97 0.09 Sep/2025
Divis Laboratories Ltd INR 21.98 3.99 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Kangmei Pharma CNY 0 0 Sep/2025
Knight Therapeutics CAD 0.03 0.06 Sep/2025
Laboratorios Farma EUR 1.96 0.71 Dec/2023
Malin Corporation EUR -0.06 0.1 Dec/2023
Medical Developments International AUD 0 0 Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Neuren Pharmaceuticals AUD 0.12 0.06 Dec/2025
Organigram Holdings CAD -0.18 0.13 Sep/2025
Ovoca Bio EUR -0.07 0.04 Jun/2022
Pacira USD 0.06 0.64 Dec/2025
Perrigo USD 0.77 0.03 Dec/2025
Pharma Mar EUR 3.34 3.57 Dec/2025
Qiagen NV USD 0.52 0.01 Dec/2025
Sartorius EUR 1.26 0.63 Dec/2025
Sino Biopharmaceutical CNY 0.16 0.07 Jun/2025
Supernus Pharmaceuticals USD -0.07 0.73 Dec/2025
Tilray USD -0.41 0.4 Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 1.53 0.8 Sep/2025